Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Novel Drug Combinations for Advanced Breast Cancer
Link ID 2545
Title Novel Drug Combinations for Advanced Breast Cancer
Url http://www.medscape.com/viewarticle/568165?src=rss
Description In this Expert Interview from SABCS 2007, Dr. William J. Gradishar details the latest novel drug combinations that may benefit patients with advanced breast cancer.
Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Jan 19, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients With C
  How can clinicians improve on the prevention and treatment of potentially fatal venous thromboembolism in the patient with cancer? Pharmacotherapy
Category:   Articles > Hematology-Oncology


2. Treatment of ocular surface squamous neoplasia with Mitomycin C
  How effective is mitomycin-C in the treatment regimen of conjunctival-corneal intraepithelial neoplasia? The British Journal of Ophthalmology
Category:   Articles > Hematology-Oncology


3. A 2-Year-Old Boy With Redness, Discharge, and Swelling of his Right Eye
  A 2-year-old African-American male presents with a 3-day history of redness and discharge from the right eye, and a 1-day history of swelling of the eye. What might be the diagnosis? Medscape Ophthalmology
Category:   Articles > Hematology-Oncology


4. Fewer Side Effects With Pemetrexed in Patients With NSCLC
  Pemetrexed is safe and well tolerated and makes cisplatin a more useful drug for patients with NSCLC. Dr. Mark Kris discusses the advantages of this combination regimen. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Bleomycin Being Underdosed in Advanced Germ Cell Tumors?
  A study of bleomycin toxicity showed that asymptomatic drops in lung function scores caused 20% of bleomycin doses to be missed and 20% of patients to receive less than their planned doses. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS